Prevalence of Human Papillomavirus (HPV) and HPV Vaccination Completion Rates Among Gay and Bisexual Men in Dar es Salaam, Tanzania

High-risk Human Papillomavirus (HPV) is a sexually transmissible virus that causes cancer. Vaccination against HPV is available up to age 45. Gay and bisexual men (GBM) are at high risk for oropharyngeal and anal cancers caused by HPV. As part of a larger study of HPV prevention in GBM, we obtained...

Full description

Saved in:
Bibliographic Details
Main Authors: Lucy R. Mgopa, Ever Mkonyi, Mabula Kasubi, Alan G. Nyitray, Michael W. Ross
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Venereology
Subjects:
Online Access:https://www.mdpi.com/2674-0710/4/1/1
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849340145853005824
author Lucy R. Mgopa
Ever Mkonyi
Mabula Kasubi
Alan G. Nyitray
Michael W. Ross
author_facet Lucy R. Mgopa
Ever Mkonyi
Mabula Kasubi
Alan G. Nyitray
Michael W. Ross
author_sort Lucy R. Mgopa
collection DOAJ
description High-risk Human Papillomavirus (HPV) is a sexually transmissible virus that causes cancer. Vaccination against HPV is available up to age 45. Gay and bisexual men (GBM) are at high risk for oropharyngeal and anal cancers caused by HPV. As part of a larger study of HPV prevention in GBM, we obtained anal swabs for HPV and offered HPV vaccination to GBM in Dar es Salaam, Tanzania. Participants were recruited by an outreach worker experienced with the GBM subculture using Respondent-Driven Sampling (RDS) from seeds. Eighty-three of a possible one hundred participants (mean age 26) were enrolled, tested, and given a first vaccination dose. Anal swabs were tested for twenty-eight HPV genotypes, both high and low risk for carcinogenicity, and a median of seven different HPV genotypes was found in participants. A total of 87% of participants carried at least one HPV genotype, and 76% carried at least one high-risk genotype. As a result of harassment and unanticipated risk to participants and staff at the unmarked community-based site, this study was terminated before the sample size was reached. Since a full course of vaccine was the standard of care, participants were contacted using the contact method they had provided to arrange follow-up vaccination doses at an alternative clinical site. Twenty-nine percent received the additional vaccination. A further 6% made appointments but did not attend, and another 10% would have received the second vaccination if they were incentivized to attend. The rate of HPV in anal samples was significantly higher than in our study using the same recruitment method in the same city in 2011–2012. The HIV rate was 45%. Anal HPV rates, including high-risk HPV rates, were significantly higher than in a similar population of gay and bisexual men 12 years ago. It is possible to provide HPV vaccination to gay and bisexual men in Tanzania and have approximately 45% potentially re-attend for a second dose if they are incentivized. Great care must be used to situate vaccination to avoid stigma leading to harassment, especially where homosexuality is criminalized. We infer that the high-risk harassment faced by participants and lack of incentive for the second visit depressed the return rate for revaccination.
format Article
id doaj-art-2b4a7dda9a1c444e88efa41d38c06cf0
institution Kabale University
issn 2674-0710
language English
publishDate 2024-12-01
publisher MDPI AG
record_format Article
series Venereology
spelling doaj-art-2b4a7dda9a1c444e88efa41d38c06cf02025-08-20T03:43:58ZengMDPI AGVenereology2674-07102024-12-0141110.3390/venereology4010001Prevalence of Human Papillomavirus (HPV) and HPV Vaccination Completion Rates Among Gay and Bisexual Men in Dar es Salaam, TanzaniaLucy R. Mgopa0Ever Mkonyi1Mabula Kasubi2Alan G. Nyitray3Michael W. Ross4Department of Psychiatry and Mental Health, School of Clinical Medicine, Muhimbili University of Health and Allied Sciences, Upanga Campus, Dar es Salaam P.O Box 65001, TanzaniaMedical Education Research and Evaluation, Case Western Reserve University, Cleveland, OH 44106, USAMuhimbili National Hospital, Dar es Salaam P.O. Box 65000, TanzaniaCenter for AIDS Intervention Research (CAIR), Department of Psychiatry and Behavioral Medicine, Medical College of Wisconsin, Milwaukee, WI 53202, USAInstitute of Sexual and Gender Health, Department of Family Medicine, University of Minnesota, Minneapolis, MN 55454, USAHigh-risk Human Papillomavirus (HPV) is a sexually transmissible virus that causes cancer. Vaccination against HPV is available up to age 45. Gay and bisexual men (GBM) are at high risk for oropharyngeal and anal cancers caused by HPV. As part of a larger study of HPV prevention in GBM, we obtained anal swabs for HPV and offered HPV vaccination to GBM in Dar es Salaam, Tanzania. Participants were recruited by an outreach worker experienced with the GBM subculture using Respondent-Driven Sampling (RDS) from seeds. Eighty-three of a possible one hundred participants (mean age 26) were enrolled, tested, and given a first vaccination dose. Anal swabs were tested for twenty-eight HPV genotypes, both high and low risk for carcinogenicity, and a median of seven different HPV genotypes was found in participants. A total of 87% of participants carried at least one HPV genotype, and 76% carried at least one high-risk genotype. As a result of harassment and unanticipated risk to participants and staff at the unmarked community-based site, this study was terminated before the sample size was reached. Since a full course of vaccine was the standard of care, participants were contacted using the contact method they had provided to arrange follow-up vaccination doses at an alternative clinical site. Twenty-nine percent received the additional vaccination. A further 6% made appointments but did not attend, and another 10% would have received the second vaccination if they were incentivized to attend. The rate of HPV in anal samples was significantly higher than in our study using the same recruitment method in the same city in 2011–2012. The HIV rate was 45%. Anal HPV rates, including high-risk HPV rates, were significantly higher than in a similar population of gay and bisexual men 12 years ago. It is possible to provide HPV vaccination to gay and bisexual men in Tanzania and have approximately 45% potentially re-attend for a second dose if they are incentivized. Great care must be used to situate vaccination to avoid stigma leading to harassment, especially where homosexuality is criminalized. We infer that the high-risk harassment faced by participants and lack of incentive for the second visit depressed the return rate for revaccination.https://www.mdpi.com/2674-0710/4/1/1HPVgay and bisexual menanalvaccinationAfricaTanzania
spellingShingle Lucy R. Mgopa
Ever Mkonyi
Mabula Kasubi
Alan G. Nyitray
Michael W. Ross
Prevalence of Human Papillomavirus (HPV) and HPV Vaccination Completion Rates Among Gay and Bisexual Men in Dar es Salaam, Tanzania
Venereology
HPV
gay and bisexual men
anal
vaccination
Africa
Tanzania
title Prevalence of Human Papillomavirus (HPV) and HPV Vaccination Completion Rates Among Gay and Bisexual Men in Dar es Salaam, Tanzania
title_full Prevalence of Human Papillomavirus (HPV) and HPV Vaccination Completion Rates Among Gay and Bisexual Men in Dar es Salaam, Tanzania
title_fullStr Prevalence of Human Papillomavirus (HPV) and HPV Vaccination Completion Rates Among Gay and Bisexual Men in Dar es Salaam, Tanzania
title_full_unstemmed Prevalence of Human Papillomavirus (HPV) and HPV Vaccination Completion Rates Among Gay and Bisexual Men in Dar es Salaam, Tanzania
title_short Prevalence of Human Papillomavirus (HPV) and HPV Vaccination Completion Rates Among Gay and Bisexual Men in Dar es Salaam, Tanzania
title_sort prevalence of human papillomavirus hpv and hpv vaccination completion rates among gay and bisexual men in dar es salaam tanzania
topic HPV
gay and bisexual men
anal
vaccination
Africa
Tanzania
url https://www.mdpi.com/2674-0710/4/1/1
work_keys_str_mv AT lucyrmgopa prevalenceofhumanpapillomavirushpvandhpvvaccinationcompletionratesamonggayandbisexualmenindaressalaamtanzania
AT evermkonyi prevalenceofhumanpapillomavirushpvandhpvvaccinationcompletionratesamonggayandbisexualmenindaressalaamtanzania
AT mabulakasubi prevalenceofhumanpapillomavirushpvandhpvvaccinationcompletionratesamonggayandbisexualmenindaressalaamtanzania
AT alangnyitray prevalenceofhumanpapillomavirushpvandhpvvaccinationcompletionratesamonggayandbisexualmenindaressalaamtanzania
AT michaelwross prevalenceofhumanpapillomavirushpvandhpvvaccinationcompletionratesamonggayandbisexualmenindaressalaamtanzania